Identifying patients at high risk of progression and early death among those with high-tumor-burden follicular lymphoma (FL) is unsatisfactory with current prognostic models. This study aimed to determine the prognostic impact of the total metabolic tumor volume (TMTV) measured at baseline with [(18)F]fluorodeoxyglucose/positron emission tomography-computed tomography ([(18)F]FDG/PET-CT) scans and its added value to these models.
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies / Meignan, Michel; Cottereau, Anne Ségolène; Versari, Annibale; Chartier, Loïc; Dupuis, Jehan; Boussetta, Sami; Grassi, Ilaria; Casasnovas, René Olivier; Haioun, Corinne; Tilly, Hervé; Tarantino, Vittoria; Dubreuil, Julien; Federico, Massimo; Salles, Gilles; Luminari, Stefano; Trotman, Judith. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 34:(2016), pp. 3618-3626. [10.1200/JCO.2016.66.9440]
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies
Tarantino, Vittoria;FEDERICO, Massimo;LUMINARI, Stefano;
2016
Abstract
Identifying patients at high risk of progression and early death among those with high-tumor-burden follicular lymphoma (FL) is unsatisfactory with current prognostic models. This study aimed to determine the prognostic impact of the total metabolic tumor volume (TMTV) measured at baseline with [(18)F]fluorodeoxyglucose/positron emission tomography-computed tomography ([(18)F]FDG/PET-CT) scans and its added value to these models.File | Dimensione | Formato | |
---|---|---|---|
437.pdf
Accesso riservato
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
907.86 kB
Formato
Adobe PDF
|
907.86 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris